International Normalized Ratios (INR)
Is the incidence and prevalence of inhibitors greater with recombinant products? Yes
Is the incidence and prevalence of inhibitors greater with recombinant products? No
The complex hunt for genes influencing complex disease
Genome scan of venous thrombosis in a pedigree with protein C deficiency
Has time come for screening for occult cancer in patients with venous thromboembolism?
Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism
The ethics of Zelen consent
Extensive screening for occult malignant disease in idiopathic venous thromboembolism
Are the bleeding time and PFA-100® useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?
Template bleeding time and PFA-100® have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages
Recombinant factor VIIa
Characterization of an immunologic polymorphism (D79H) in the heavy chain of factor V
A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency
Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis1
Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis
The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties
Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions
Prion protein stimulates tissue-type plasminogen activator-mediated plasmin generation via a lysine-binding site on kringle 2
The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented
Different G protein-coupled signaling pathways are involved in α granule release from human platelets
Delayed thrombocytopenia after treatment with abciximab
αIIbβ3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium
Laboratory monitoring of low-molecular-weight heparin therapy
Laboratory monitoring of low-molecular-weight heparin therapy
Laboratory monitoring of low-molecular-weight heparin therapy
Laboratory monitoring of low-molecular-weight heparin therapy
Laboratory monitoring of low-molecular-weight heparin therapy
Venous stasis and thrombin generation
Soluble monocyte cluster domain 163, a new global marker of anti-inflammatory response, is elevated in the first trimester of pregnancy
IgG formation to mammalian proteins in hemophilia A patients following treatment with a new recombinant human factor VIII
Prevalence of protein S deficiency in the Japanese general population
The FcγRIIa His131Arg polymorphism and its association with myocardial infarction
Factor XI gene analysis in thrombophilia and factor XI deficiency
Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency
Independence of tumor necrosis factor-α-induced adhesion molecule expression from sphingosine 1-phosphate signaling in vascular endothelial cells
More on
Choice of replacement therapy for hemophilia—cryoprecipitate issues
WFH policy on selection of coagulation factor concentrates
WFH policy on selection of coagulation factor concentrates
ANNOUNCEMENTS
ERRATUM